Related Experiment Video
Updated: Sep 21, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
REFLECTions on Combination Therapies Empowered by Data Sharing
Trevor J Pugh1,2,3, Benjamin Haibe-Kains1,2,3,4,5
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Summary:
Li and colleagues present REFLECT, a computational approach to precision oncology that nominates effective drug combinations by utilizing a diverse compendium of publicly available preclinical and clinical genomic, transcriptomic, and proteomic data. The preliminary validation of the REFLECT system in preclinical and clinical trial settings showcases potential for clinical implementation, although challenges remain. See related article by Li et al., p. 1542 (4).
Insights
Researchers developed REFLECT, a computational method to identify effective cancer drug combinations using diverse biological data. Early validation suggests potential for clinical use in precision oncology, though further development is needed.
Area of Science:
- Computational biology
- Genomics
- Proteomics
- Transcriptomics
- Precision oncology
Background:
- Precision oncology aims to tailor cancer treatments to individual patients.
- Identifying effective drug combinations remains a significant challenge in oncology.
- Leveraging multi-omics data can enhance treatment selection.
Discussion:
- The REFLECT system integrates genomic, transcriptomic, and proteomic data.
- It nominates synergistic drug combinations for cancer therapy.
- The approach utilizes publicly available preclinical and clinical data.
Key Insights:
- REFLECT demonstrates a computational strategy for precision oncology.
- Preliminary validation shows promise for clinical application.
- The system's ability to nominate effective drug combinations was assessed.
Outlook:
- Further validation and refinement are necessary for widespread clinical implementation.
- REFLECT has the potential to advance personalized cancer treatment strategies.
- Challenges in data integration and model generalizability require ongoing research.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug Therapy
Antianxiety Medications
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...

